Orion Oyj

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FI0009014377
EUR
67.30
0.4 (0.6%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

130.0 k

Shareholding (Dec 2025)

FII

0.00%

Held by 1 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 9,469 Million ()

stock-summary
P/E

20.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.15

stock-summary
Return on Equity

38.95%

stock-summary
Price to Book

7.37

Revenue and Profits:
Net Sales:
695 Million
(Quarterly Results - Dec 2025)
Net Profit:
260 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
5.9%
0%
5.9%
6 Months
5.57%
0%
5.57%
1 Year
25.79%
0%
25.79%
2 Years
95.19%
0%
95.19%
3 Years
65.28%
0%
65.28%
4 Years
67.7%
0%
67.7%
5 Years
98.41%
0%
98.41%

Orion Oyj for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
11.88%
EBIT Growth (5y)
17.93%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0.11
Net Debt to Equity (avg)
0.06
Sales to Capital Employed (avg)
1.24
Tax Ratio
20.16%
Dividend Payout Ratio
50.61%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
40.73%
ROE (avg)
29.77%

Valuation key factors

Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
7.63
EV to EBIT
15.85
EV to EBITDA
14.54
EV to Capital Employed
7.00
EV to Sales
5.26
PEG Ratio
0.39
Dividend Yield
NA
ROCE (Latest)
44.15%
ROE (Latest)
38.95%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Bullish
OBV
Mildly Bearish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 64.49% vs 1.42% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 171.35% vs 16.36% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "695.30",
          "val2": "422.70",
          "chgp": "64.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "342.30",
          "val2": "133.40",
          "chgp": "156.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.10",
          "val2": "0.60",
          "chgp": "83.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "260.50",
          "val2": "96.00",
          "chgp": "171.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "470.90%",
          "val2": "282.20%",
          "chgp": "18.87%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 22.47% vs 29.39% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 51.65% vs 52.17% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,887.80",
          "val2": "1,541.40",
          "chgp": "22.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "681.30",
          "val2": "498.70",
          "chgp": "36.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.70",
          "val2": "8.40",
          "chgp": "3.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.40",
          "val2": "-38.00",
          "chgp": "98.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "500.30",
          "val2": "329.90",
          "chgp": "51.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "331.10%",
          "val2": "290.20%",
          "chgp": "4.09%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
695.30
422.70
64.49%
Operating Profit (PBDIT) excl Other Income
342.30
133.40
156.60%
Interest
1.10
0.60
83.33%
Exceptional Items
0.00
0.00
Consolidate Net Profit
260.50
96.00
171.35%
Operating Profit Margin (Excl OI)
470.90%
282.20%
18.87%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 64.49% vs 1.42% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 171.35% vs 16.36% in Sep 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
1,887.80
1,541.40
22.47%
Operating Profit (PBDIT) excl Other Income
681.30
498.70
36.62%
Interest
8.70
8.40
3.57%
Exceptional Items
-0.40
-38.00
98.95%
Consolidate Net Profit
500.30
329.90
51.65%
Operating Profit Margin (Excl OI)
331.10%
290.20%
4.09%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 22.47% vs 29.39% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 51.65% vs 52.17% in Dec 2024

stock-summaryCompany CV
About Orion Oyj stock-summary
stock-summary
Orion Oyj
Pharmaceuticals & Biotechnology
Orion Oyj, previously Orion Corporation, is a Finland-based company active within the pharmaceutical industry. The Company is engaged in the research and development, manufacture and marketing of human and veterinary pharmaceuticals and active pharmaceutical ingredients. The core therapy areas of the Company's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases.
Company Coordinates stock-summary
Company Details
Orionintie 1A , ESPOO None : 02200
stock-summary
Tel: 358 10 4261358 10 4262883
stock-summary
Registrar Details